手机版 客户端
《DRUGS IN R&D》杂志封面

《DRUGS IN R&D》中科院JCR分区

  • 2025年3月升级版:
  • 大类小类学科Top综述期刊
    医学 4区
    PHARMACOLOGY & PHARMACY
    药学
    4区

  • 2023年12月升级版:
  • 大类小类学科Top综述期刊
    医学 4区
    PHARMACOLOGY & PHARMACY
    药学
    4区

    《DRUGS IN R&D》期刊简介:

    Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.

    The Journal includes:

    Clinical research on new and established drugs;
    Preclinical research of direct relevance to clinical drug development;
    Short communications and case study reports that meet the above criteria will also be considered;
    Reviews may also be considered.

  • 浏览下载本刊EndNote stylesEndNote styles
  • 《DRUGS IN R&D》其他相关信息:

    《DRUGS IN R&D》评估说明

      《DRUGS IN R&D》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《DRUGS R&D 》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《DRUGS R&D 》" 的价值还取决于各种因素的综合分析。

    此文由爱科学编辑!:首页 > SCI期刊 > 医学 » DRUGS IN R&D

    《DRUGS IN R&D》投稿经验分享